| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $434.3M | +28.6% |
| Cost of Revenue | $262.5M | +27.0% |
| Gross Profit | $171.8M | +31.3% |
| R&D Expense | $92.4M | +3.8% |
| SG&A Expense | $88.6M | +26.2% |
| Operating Income | -$76.6M | +8.7% |
| Pre-tax Income | -$93.8M | -5.8% |
| Income Tax | $2.5M | +33.4% |
| Net Income | -$96.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $370.9M | +376.1% |
| Accounts Receivable | $81.6M | +10.6% |
| Current Assets | $469.6M | +187.7% |
| Total Assets | $733.1M | +93.5% |
| Current Liabilities | $94.2M | +23.1% |
| Total Liabilities | $105.4M | -38.6% |
| Stockholders' Equity | $627.7M | +163.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$30.9M | +55.9% |
| Capital Expenditures | $1.7M | +54.1% |
| Investing Cash Flow | -$45.8M | -929.1% |
| Financing Cash Flow | $368.3M | +358.8% |
| Free Cash Flow | -$32.5M | +54.2% |
| -6.7% |
| EPS (Basic) | -$2.92 | +59.5% |
| EPS (Diluted) | -$2.92 | +59.5% |